Search

everythinglearnresearchcommunity

for

Search:↓

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Hydroxychloroquine may help treat alopecia areata in children.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Methotrexate can help some kids with severe hair loss regrow hair.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Treatments for melanin disorders exist, but more effective options needed.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Alopecia areata treatment varies, with no optimal method established yet.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Some alopecia treatments might help treat COVID-19, but more research is needed.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.